R&D Overview


Surfactant Programs

OP0201 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP0201 is being developed as a potential first-in-class treatment option for patients with otitis media (“OM”) and Eustachian tube dysfunction (“ETD”). OM and ETD are common medical conditions of the middle ear that affect more than 700 million adults and children each year. OM is a common disorder seen in pediatric practices and is the most frequent reason children are prescribed antibiotics and undergo surgery.

Foam Programs

OP0102 or other foam-based products may be developed in the future for delivery of drugs into the ear, nose, and sinus cavities.